104 related articles for article (PubMed ID: 35841843)
21. Increased breast cancer mortality due to treatment delay and needle biopsy type: a retrospective analysis of SEER-medicare.
Pathak R; Leslie M; Dondapati P; Davis R; Tanaka K; Jett E; Chervoneva I; Tanaka T
Breast Cancer; 2023 Jul; 30(4):627-636. PubMed ID: 37130988
[TBL] [Abstract][Full Text] [Related]
22. Nomograms for Estimating Cause-Specific Death Rates of Patients With Inflammatory Breast Cancer: A Competing-Risks Analysis.
Xu F; Yang J; Han D; Huang Q; Li C; Zheng S; Wang H; Lyu J
Technol Cancer Res Treat; 2021; 20():15330338211016371. PubMed ID: 34013802
[TBL] [Abstract][Full Text] [Related]
23. Adjuvant treatment and survival in older women with triple negative breast cancer: A Surveillance, Epidemiology, and End Results analysis.
Kozak MM; Xiang M; Pollom EL; Horst KC
Breast J; 2019 May; 25(3):469-473. PubMed ID: 30925635
[TBL] [Abstract][Full Text] [Related]
24. Effect of very small tumor size on cancer-specific mortality in node-positive breast cancer.
Wo JY; Chen K; Neville BA; Lin NU; Punglia RS
J Clin Oncol; 2011 Jul; 29(19):2619-27. PubMed ID: 21606424
[TBL] [Abstract][Full Text] [Related]
25. Immediate breast reconstruction for women having inflammatory breast cancer in the United States.
Patel SA; Ng M; Nardello SM; Ruth K; Bleicher RJ
Cancer Med; 2018 Jul; 7(7):2887-2902. PubMed ID: 29761885
[TBL] [Abstract][Full Text] [Related]
26. Competing Risk of Death in Elderly Patients with Newly Diagnosed Stage I Breast Cancer.
Wasif N; Neville M; Gray R; Cronin P; Pockaj BA
J Am Coll Surg; 2019 Jul; 229(1):30-36.e1. PubMed ID: 30930100
[TBL] [Abstract][Full Text] [Related]
27. Hormone receptor status, tumor characteristics, and prognosis: a prospective cohort of breast cancer patients.
Dunnwald LK; Rossing MA; Li CI
Breast Cancer Res; 2007; 9(1):R6. PubMed ID: 17239243
[TBL] [Abstract][Full Text] [Related]
28. Obesity, physical activity, and breast cancer survival among older breast cancer survivors in the Cancer Prevention Study-II Nutrition Cohort.
Maliniak ML; Patel AV; McCullough ML; Campbell PT; Leach CR; Gapstur SM; Gaudet MM
Breast Cancer Res Treat; 2018 Jan; 167(1):133-145. PubMed ID: 28856470
[TBL] [Abstract][Full Text] [Related]
29. Effects of interval between age at first pregnancy and age at diagnosis on breast cancer survival according to menopausal status: a register-based study in Korea.
Lee J; Oh M;
BMC Womens Health; 2014 Sep; 14():113. PubMed ID: 25231360
[TBL] [Abstract][Full Text] [Related]
30. Risk of contralateral breast cancer according to first breast cancer characteristics among women in the USA, 1992-2016.
Ramin C; Withrow DR; Davis Lynn BC; Gierach GL; Berrington de González A
Breast Cancer Res; 2021 Feb; 23(1):24. PubMed ID: 33596988
[TBL] [Abstract][Full Text] [Related]
31. Breast-Conserving Therapy Versus Mastectomy in Young Breast Cancer Patients Concerning Molecular Subtypes: A SEER Population-Based Study.
Yu P; Tang H; Zou Y; Liu P; Tian W; Zhang K; Xie X; Ye F
Cancer Control; 2020; 27(1):1073274820976667. PubMed ID: 33356518
[TBL] [Abstract][Full Text] [Related]
32. Competing Nomogram for Late-Period Breast Cancer-Specific Death in Patients with Early-Stage Hormone Receptor-Positive Breast Cancer.
Zhu J; Zheng H; Ge C; Lin H; Yu K; Wu L; Li D; Zhou S; Tang W; Wang Q; Zhang X; Jin X; Xu X; Du J; Fu J
Clin Breast Cancer; 2022 Apr; 22(3):e296-e309. PubMed ID: 34627728
[TBL] [Abstract][Full Text] [Related]
33. Nomogram for Predicting Breast Cancer-Specific Mortality of Elderly Women with Breast Cancer.
Lu X; Li X; Ling H; Gong Y; Guo L; He M; Sun H; Hu X
Med Sci Monit; 2020 Sep; 26():e925210. PubMed ID: 32920589
[TBL] [Abstract][Full Text] [Related]
34. Breast cancer-specific mortality in small-sized tumor with node-positive breast cancer: a nation-wide study in Korean breast cancer society.
Ryu JM; Lee HJ; Yoon TI; Lee ES; Lee SJ; Jung JH; Chae BJ; Nam SJ; Lee JE; Lee SK; Bae SY; Yu J; Kim SW;
Breast Cancer Res Treat; 2016 Oct; 159(3):489-98. PubMed ID: 27590199
[TBL] [Abstract][Full Text] [Related]
35. The association between vascular endothelial growth factor expression in invasive breast cancer and survival varies with intrinsic subtypes and use of adjuvant systemic therapy: results from the Nurses' Health Study.
Liu Y; Tamimi RM; Collins LC; Schnitt SJ; Gilmore HL; Connolly JL; Colditz GA
Breast Cancer Res Treat; 2011 Aug; 129(1):175-84. PubMed ID: 21390493
[TBL] [Abstract][Full Text] [Related]
36. Predictors of time to death after distant recurrence in breast cancer patients.
Sopik V; Sun P; Narod SA
Breast Cancer Res Treat; 2019 Jan; 173(2):465-474. PubMed ID: 30328050
[TBL] [Abstract][Full Text] [Related]
37. Association between prolonged metastatic free interval and recurrent metastatic breast cancer survival: findings from the SEER database.
Chang E; Mougalian SS; Adelson KB; Young MR; Yu JB
Breast Cancer Res Treat; 2019 Jan; 173(1):209-216. PubMed ID: 30242577
[TBL] [Abstract][Full Text] [Related]
38. Clinical Characteristics and Outcomes of Single Versus Double Hormone Receptor-Positive Breast Cancer in 2 Large Databases.
Li Z; Tu Y; Wu Q; Wang Z; Li J; Zhang Y; Sun S
Clin Breast Cancer; 2020 Apr; 20(2):e151-e163. PubMed ID: 31551181
[TBL] [Abstract][Full Text] [Related]
39. Metastatic breast cancer survival improvement restricted by regional disparity: Surveillance, Epidemiology, and End Results and institutional analysis: 1990 to 2011.
Malmgren JA; Calip GS; Atwood MK; Mayer M; Kaplan HG
Cancer; 2020 Jan; 126(2):390-399. PubMed ID: 31639221
[TBL] [Abstract][Full Text] [Related]
40. Surgical Delay-Associated Mortality Risk Varies by Subtype in Loco-Regional Breast Cancer Patients in SEER-Medicare.
Leslie M; Pathak R; Dooley WC; Squires RA; Rui H; Chervoneva I; Tanaka T
Res Sq; 2024 Apr; ():. PubMed ID: 38659868
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
